Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells
Authors
Keywords
STAT3, Triple-negative breast cancer, Obatoclax analog, SHP-1, RFX-1
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 146, Issue 1, Pages 71-84
Publisher
Springer Nature
Online
2014-06-06
DOI
10.1007/s10549-014-3000-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Triple-negative breast cancer: epidemiological considerations and recommendations
- (2012) P. Boyle ANNALS OF ONCOLOGY
- Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody
- (2012) Kuen-Feng Chen et al. BRITISH JOURNAL OF PHARMACOLOGY
- A novel obatoclax derivative, SC-2001, induces apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation
- (2012) Kuen-Feng Chen et al. CANCER LETTERS
- Synthesis and biological activity of obatoclax derivatives as novel and potent SHP-1 agonists
- (2012) Jung-Chen Su et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeted therapy for triple-negative breast cancer: Where are we?
- (2012) Michael J. Duffy et al. INTERNATIONAL JOURNAL OF CANCER
- Regulatory Factor X1-induced Down-regulation of Transforming Growth Factor β2 Transcription in Human Neuroblastoma Cells
- (2012) Chenzhuo Feng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Suppressor of Cytokine Signaling 3 Inhibits Breast Tumor Kinase Activation of STAT3
- (2012) Yiwei Gao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Icariside II Induces Apoptosis in U937 Acute Myeloid Leukemia Cells: Role of Inactivation of STAT3-Related Signaling
- (2012) Sang-Hun Kang et al. PLoS One
- SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemia
- (2011) N. Esposito et al. BLOOD
- Gambogic Acid Inhibits STAT3 Phosphorylation through Activation of Protein Tyrosine Phosphatase SHP-1: Potential Role in Proliferation and Apoptosis
- (2011) Sahdeo Prasad et al. Cancer Prevention Research
- The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
- (2011) Lauren L.C. Marotta et al. JOURNAL OF CLINICAL INVESTIGATION
- Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma
- (2011) Wei-Tien Tai et al. JOURNAL OF HEPATOLOGY
- Breast Cancer Cells Proliferation Is Regulated by Tyrosine Phosphatase SHP1 through c-jun N-Terminal Kinase and Cooperative Induction of RFX-1 and AP-4 Transcription Factors
- (2011) S. Amin et al. MOLECULAR CANCER RESEARCH
- Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737
- (2011) S. R. Oakes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Study of FoxA Pioneer Factor at Silent Genes Reveals Rfx-Repressed Enhancer at Cdx2 and a Potential Indicator of Esophageal Adenocarcinoma Development
- (2011) Jason A. Watts et al. PLoS Genetics
- Triple-Negative Breast Cancer
- (2010) Anthony D. Elias AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent
- (2010) Peramaiyan Rajendran et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inhibition of MCL-1 enhances Lapatinib toxicity and overcomes lapatinib resistance via BAK-dependent autophagy
- (2010) Aditi Pandya Martin et al. CANCER BIOLOGY & THERAPY
- Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
- (2010) L. Lin et al. CANCER RESEARCH
- Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3
- (2010) K.-F. Chen et al. CLINICAL CANCER RESEARCH
- Regulation ofFGF1Gene Promoter through Transcription Factor RFX1
- (2010) Yi-Chao Hsu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Emerging Targeted Therapies for Breast Cancer
- (2010) Ricardo H. Alvarez et al. JOURNAL OF CLINICAL ONCOLOGY
- 5-Hydroxy-2-Methyl-1,4-Naphthoquinone, a Vitamin K3 Analogue, Suppresses STAT3 Activation Pathway through Induction of Protein Tyrosine Phosphatase, SHP-1: Potential Role in Chemosensitization
- (2010) S. K. Sandur et al. MOLECULAR CANCER RESEARCH
- Elevated Expression of the Tyrosine Phosphatase SHP-1 Defines a Subset of High-Grade Breast Tumors
- (2010) Luigi Insabato et al. ONCOLOGY
- Boswellic Acid Blocks Signal Transducers and Activators of Transcription 3 Signaling, Proliferation, and Survival of Multiple Myeloma via the Protein Tyrosine Phosphatase SHP-1
- (2009) Ajaikumar B. Kunnumakkara et al. MOLECULAR CANCER RESEARCH
- Mimicking the BH3 domain to kill cancer cells
- (2009) T Ni Chonghaile et al. ONCOGENE
- Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells
- (2009) N J Sullivan et al. ONCOGENE
- Bcl-2 family members as molecular targets in cancer therapy
- (2008) Isabel Marzo et al. BIOCHEMICAL PHARMACOLOGY
- Mechanisms of Antileukemic Activity of the Novel Bcl-2 Homology Domain-3 Mimetic GX15-070 (Obatoclax)
- (2008) M. Konopleva et al. CANCER RESEARCH
- Tumor resistance to apoptosis
- (2008) Simone Fulda INTERNATIONAL JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More